JAK1 and allergic asthma: Finally, qPCR, flow cytometry, and Westernblotting were used to validate that JGT inhibited Th2 cell differentiationby blocking the JAK1-STAT6 signaling pathway in CD4+ Tcells, ultimately improving allergic asthma.